These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune Response. Mehraj V; Ponte R; Routy JP EBioMedicine; 2016 Jul; 9():37-44. PubMed ID: 27397514 [TBL] [Abstract][Full Text] [Related]
43. Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Una de Gato and Sangre de Grado. Williams JE Altern Med Rev; 2001 Dec; 6(6):567-79. PubMed ID: 11804547 [TBL] [Abstract][Full Text] [Related]
44. [Means of body defense against viral infections]. Fauconnier B Nouv Presse Med; 1972 Jan; 1(2):113-8. PubMed ID: 5010746 [No Abstract] [Full Text] [Related]
47. [Virus infections]. Seige G Med Monatsschr Pharm; 1993 Aug; 16(8):239-43. PubMed ID: 8377715 [No Abstract] [Full Text] [Related]
48. Antiviral therapy with non-selective beta-blockers: preliminary experimental and clinical corroboration. Peuschel KE Med Hypotheses; 2005; 64(2):256-60. PubMed ID: 15607550 [TBL] [Abstract][Full Text] [Related]
49. Dampening antiviral immunity can protect the host. Panetti C; Kao KC; Joller N FEBS J; 2022 Feb; 289(3):634-646. PubMed ID: 33570771 [TBL] [Abstract][Full Text] [Related]
50. Immune Checkpoints in Viral Infections. Cai H; Liu G; Zhong J; Zheng K; Xiao H; Li C; Song X; Li Y; Xu C; Wu H; He Z; Zhu Q Viruses; 2020 Sep; 12(9):. PubMed ID: 32967229 [TBL] [Abstract][Full Text] [Related]
51. Vaccine, chemotherapy, and host resistance approaches to control of viral respiratory disease. Hilleman MR Manit Med Rev; 1966 Mar; 46(3):200-5. PubMed ID: 5906025 [No Abstract] [Full Text] [Related]
52. Uncommon illness from common infections. Christian CL Trans Am Clin Climatol Assoc; 1988; 99():111-8. PubMed ID: 3332514 [TBL] [Abstract][Full Text] [Related]
53. The protective and pathogenic roles of IL-17 in viral infections: friend or foe? Ma WT; Yao XT; Peng Q; Chen DK Open Biol; 2019 Jul; 9(7):190109. PubMed ID: 31337278 [TBL] [Abstract][Full Text] [Related]
54. Role of biological modifiers regulating the immune response after trauma. Stahel PF; Smith WR; Moore EE Injury; 2007 Dec; 38(12):1409-22. PubMed ID: 18048034 [TBL] [Abstract][Full Text] [Related]
55. Oral immune regulation: a new mode of therapy against chronic viral infections. Levy L; Ilan Y Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):217-21. PubMed ID: 18221179 [TBL] [Abstract][Full Text] [Related]
56. An immunologist's view of viral disease. Penny R Aust Fam Physician; 1978 May; 7(5):507-13. PubMed ID: 666664 [TBL] [Abstract][Full Text] [Related]
57. Anti-viral treatment in patients with virus-induced cardiomyopathy. Kühl U; Pauschinger M; Poller W; Schultheiss HP Ernst Schering Res Found Workshop; 2006; (55):323-42. PubMed ID: 16329670 [TBL] [Abstract][Full Text] [Related]
58. The continuing search for antiviral drugs. Buchnall RA Adv Pharmacol Chemother; 1973; 11():295-318. PubMed ID: 4585168 [No Abstract] [Full Text] [Related]
59. Potential of Interleukin (IL)-12 Group as Antivirals: Severe Viral Disease Prevention and Management. A Rahman NA; Balasubramaniam VRMT; Yap WB Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108513 [TBL] [Abstract][Full Text] [Related]